Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


A new piece for the jigsaw of breast cancer: FoxM1 regulates the expression of oestrogen receptors in breast cancer

Research just published online in the "Journal of Biological Chemistry" identifies a new molecule involved in the regulation of oestrogen receptors (ER) expression in breast cancer. Oestrogen is an hormone known to affect directly the survival and growth of breast cancer, and its activity is mediated through ER, which are, not only important prognostic factors in the disease, but also involved in the resistance to therapy observed in many of these tumours. The discovery, by elucidating part of the mechanism behind ER, can help to understand better breast cancer, and, in consequence, also the development of new and better therapies for the disease.

Breast cancer is still the most common malignancy among women with half a million deaths every year and one in nine of all females in the western world developing it sometime in their lives. Oestrogen is the major female sex hormone, crucial for the normal sex development and functioning of female organs and tissues, but also with a crucial role in the survival and development of many breast tumours. The hormone acts by binding to specific ER (ER-alpha and ER-beta) in a lock-and-key-mechanism that results in the activation, on the target tissue, of genes involved in cell survival and proliferation.

The role of oestrogen in cancer was first noticed about 100 years ago when researchers observed that removal of the ovaries – the major place for oestrogen production - in women with breast cancer substantially increased their chance of survival. We know now that this effect results from the fact that about 75% of human breast cancers are ER positive (mostly ER-alpha) and, as result, their grow and survival is directly dependent on oestrogen. This is also why men, that do not have ovaries and have much less oestrogen, present much lower breast cancer rates in comparison to women.

But to have ER-positive breast cancer is not only bad news since this type of tumours has the best prognosis, most probably because the hormonal therapies used in these cases (which disrupt oestrogen-ER activation) can be very effective.

Nevertheless, after an initial period of response many ER-positive tumours develop treatment resistance - even if in most of cases they maintain their oestrogen receptors - leading to disease relapses. This is believed to result from “over-activation” of ER, and consequent by-pass of the hormonal therapy effect, by growth factors, another type of hormones capable of activate ER. These cases, together with the 25% of breast tumours that are ER-negative, present a major challenge to an effective clinical management of the disease. As result it is crucial to understand the molecular and cellular mechanisms behind oestrogen receptors expression and activity for a wider and more effective breast cancer therapy.

In agreement with this idea, Patricia A. Madureira, Eric W.-F Lam and colleagues at Imperial College, London, UK and the University of Hong Kong in China looked for molecules capable of affect ER expression and/or activity, and found that transcription factor FoxM1 (transcription factors are proteins that bind to regulatory regions in the DNA leading to the expression or inhibition of specific genes) is a physiological regulator of ER-alpha expression in breast cancer cells.

Madureira, Lam and colleagues started by analysing cells from 16 different breast tumours to find that in 13 of them FoxM1 and ER-alpha expression showed a high correlation, suggesting some kind of functional link between the two molecules. Other experiments, such as the inhibition or, alternatively the introduction of FoxM1 expression in breast cancers cells, which led, respectively, to the reduction or the increase of ER-alpha levels in these cells, confirmed this role of FoxM1 in ER-alpha regulation.

These are findings that can have important therapeutic value because ER regulation/expression is, as here discussed, directly associated with the oestrogen-mediated mechanism that affects the survival and proliferation of tumour cells, and also, in the cases where hormonal therapy is being used, the control (or not) of the disease. To understand the mechanisms affecting the expression of these molecules is then fundamental to be able to have a better chance interfering and controlling breast cancer, a disease that, according to the World Health Organization, only in 2005 had more than a million of new cases diagnosed.

Piece researched and written by: Catarina Amorim (

Catarina Amorim | alfa
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>